Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 77 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Doulberis, Michael  [Clear All Filters]
Journal Article
Kountouras, J., Polyzos S. A., Katsinelos P., Kotronis G., & Doulberis M. (2017).  Obesity and the nervous system: more questions.. Lancet Neurol. 16(10), 772-773.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Vardaka E., Tzivras D., et al. (2019).  A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.. Ann N Y Acad Sci. 1452(1), 12-17.
Kountouras, J., Doulberis M., Polyzos S. A., Papaefthymiou A., Kapetanakis N., Arapoglou S., et al. (2018).  Potential Impact of Active Helicobacter pylori Infection with or without Concomitant Metabolic Syndrome on Colorectal Cancer Invasion and Mortality.. Isr Med Assoc J. 20(11), 725-726.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease.. Metabolism. 135, 155276.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Lazaraki G., et al. (2023).  Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.. J Viral Hepat.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2022).  Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology.. J Gastrointest Cancer.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Zavos C., Vagdatli E., et al. (2020).  Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap.. J Clin Gastroenterol. 54(2), 200-201.
Kountouras, J., Polyzos S. A., Katsinelos P., Anastasiadis S., Tzivras D., Doulberis M., et al. (2018).  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.. Dig Dis Sci. 63(4), 1087-1088.
Boziki, M., Polyzos S. A., Deretzi G., Kazakos E., Katsinelos P., Doulberis M., et al. (2018).  A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration.. Neurochem Int. 113, 137-151.
Boziki, M., Grigoriadis N., Doulberis M., Papaefthymiou A., Polyzos S. A., & Kountouras J. (2020).  Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis.. Dig Liver Dis. 52(1), 121-123.
Boziki, M., Polyzos S. A., Papaefthymiou A., Doulberis M., Bakirtzis C., Sintila S-A., et al. (2021).  Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders.. Metabolism. 154736.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kyrailidi F., & Doulberis M. (2022).  Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes.. Am J Hypertens.
Kountouras, J., Polyzos S. A., Doulberis M., Zeglinas C., Artemaki F., Vardaka E., et al. (2018).  Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.. Metabolism. 87, 18-24.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2021).  A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension.. Liver Int.
Kountouras, J., Kazakos E., Polyzos S. A., Papaefthymiou A., Zavos C., Tzitiridou-Chatzopoulou M., et al. (2023).  Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.. Clin Immunol. 256, 109776.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Vardaka E., et al. (2019).  The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies.. Scand J Gastroenterol. 1-2.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Zavos C., & Doulberis M. (2020).  Response to letter to the editor of Carcinogenesis by Li et al., 2020.. Carcinogenesis. 41(4), 539-540.
Doulberis, M., Kotronis G., Thomann R., Polyzos S. A., Boziki M., Gialamprinou D., et al. (2018).  Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?. Helicobacter. 23(1), 
Doulberis, M., Papaefthymiou A., Polyzos S. A., Katsinelos P., Grigoriadis N., Srivastava D. S., et al. (2020).  Rodent models of obesity.. Minerva Endocrinol. 45(3), 243-263.
Papaefthymiou, A., Christodoulidis G., Koffas A., Doulberis M., Polyzos S. A., Manolakis A., et al. (2021).  Role of autophagy in gastric carcinogenesis.. World J Gastrointest Oncol. 13(10), 1244-1262.
Polyzos, S. A., Kountouras J., Mavrouli M., Katsinelos P., Doulberis M., Gavana E., et al. (2019).  Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.. Exp Clin Endocrinol Diabetes.
Doulberis, M., Polyzos S. A., Papaefthymiou A., Katsinelos P., Kiosses C., & Kountouras J. (2020).  Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents.. Expert Opin Pharmacother. 21(3), 247-251.
Boziki, M., Grigoriadis N., Papaefthymiou A., Doulberis M., Polyzos S. A., Gavalas E., et al. (2021).  The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis.. Neurochem Int. 144, 104938.
Kountouras, J., Gavalas E., Papaefthymiou A., Tsechelidis I., Polyzos S. A., Bor S., et al. (2020).  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.. Medicina (Kaunas). 56(7), 

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.